Literature DB >> 18825707

Twenty years of follow-up of aortohepatic conduits in liver transplantation.

Dmitriy Nikitin1, Linda W Jennings, Tariq Khan, Edmund Q Sanchez, Srinath Chinnakotla, Henry B Randall, Greg J McKenna, Robert M Goldstein, Marlon F Levy, Goran B Klintmalm.   

Abstract

Arterial problems remain a formidable challenge in liver transplantation. In many situations, an aortohepatic conduit can provide a solution. No long-term results (over 5 years) have been reported. This study was designed to assess the impact of aortohepatic conduits on graft survival after liver transplantation and the safety of aortohepatic conduits and to establish the long-term results (up to 20 years) of aortohepatic conduits. Data from 2346 adult liver transplants were prospectively collected into the computerized database and analyzed. In the majority of cases, arterial conduits were constructed from the donor iliac artery obtained at the liver retrieval. Aortohepatic conduits were required in 149 (6.4%) first transplants. The long-term graft survival after liver transplantation using aortohepatic conduits was excellent and comparable to that of the control group. The graft survival was 59% with the conduit versus 67% without the conduit at 5 years of follow-up, 50% versus 52% at 10 years, and 33% versus 35% at 15 years. With up to 20 years of follow-up, there was no statistically significant difference in graft survival, patient survival, hepatic artery complications, or biliary complications. For the same time period, there was no statistically significant difference in graft survival or patient survival for the retransplants with and without aortohepatic conduits. In conclusion, in experienced hands, aortohepatic conduits can be used safely for liver transplantation with no negative impact on long-term graft survival, patient survival, hepatic artery complications, or biliary complications. Excellent long-term results can be obtained. (c) 2008 AASLD.

Entities:  

Mesh:

Year:  2008        PMID: 18825707     DOI: 10.1002/lt.21575

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Aorto-hepatic bypass in liver transplantation in the MELD-era: outcomes after supraceliac and infrarenal bypasses.

Authors:  Richard Hummel; Sabrina Irmscher; Christina Schleicher; Norbert Senninger; Jens G Brockmann; Heiner H Wolters
Journal:  Surg Today       Date:  2013-03-05       Impact factor: 2.549

2.  Liver Transplantation Utilizing Mixed Biologic and Synthetic Arterial Conduits.

Authors:  Marcio F Chedid; Tomaz J M Grezzana-Filho; Aljamir D Chedid; Luiz Pedro P Hendges; Ian Leipnitz; Mario R Alvares-da-Silva; Ariane N Backes; Matheus J Reis; Cleber Dario P Kruel; Cleber R P Kruel
Journal:  Case Rep Surg       Date:  2016-10-12

3.  Comparison of Supraceliac and Infrarenal Aortic Conduits in Liver Transplantation: Is There a Difference in Patency and Postoperative Renal Dysfunction?

Authors:  David Livingston; David D Lee; Sarah Croome; C Burcin Taner; Kristopher P Croome
Journal:  Transplant Direct       Date:  2019-10-08

4.  Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?

Authors:  Matthew B Goss; N Thao N Galván; Joseph D Geha; Nicolas F Moreno; Ronald T Cotton; Abbas Rana; Christine A O'Mahony; John A Goss
Journal:  Transplant Direct       Date:  2021-01-26

5.  Concurrent hepatic artery and portal vein thrombosis after orthotopic liver transplantation with preserved allografts.

Authors:  Arshad Khan; P Park; Jose Oberholzer; Ivo Tzvetanov; Raquel Garcia Roca; Ron C Gaba; Enrico Benedetti; Hoonbae Jeon
Journal:  Case Rep Transplant       Date:  2014-04-10

Review 6.  Current state of art management for vascular complications after liver transplantation.

Authors:  S Kamran Hejazi Kenari; Asha Zimmerman; Mohammad Eslami; Reza F Saidi
Journal:  Middle East J Dig Dis       Date:  2014-07

7.  Placement of an Aortohepatic Conduit as an Alternative to Standard Arterial Anastomosis in Liver Transplantation.

Authors:  Dong-Hwan Jung; Cheon-Soo Park; Tae-Yong Ha; Gi-Won Song; Gil-Chun Park; Yong-Pil Cho; Sung-Gyu Lee
Journal:  Ann Transplant       Date:  2018-01-19       Impact factor: 1.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.